Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Glulisine vs Lispro in Diabetes Mellitus
NCT00467376Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 2007
- Primary completion
- Jun 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glulisine in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jan 2007; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00467376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467376.